Caption Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-245,000	Closed	-$32.3M	–	2010
2025 Q1	$32.3M	Buy	+245,000	New	+$30.5M	0.31%	56
2024 Q3	–	Sell	-60,000	Closed	-$4.11M	–	1653
2024 Q2	$4.11M	Sell	60,000 -78,600	-57%	-$5.45M	0.06%	304
2024 Q1	$9.59M	Buy	138,600 +136,500	+6,500%	+$9.38M	0.15%	179
2023 Q4	$150K	Sell	2,100 -52,900	-96%	-$3.04M	﹤0.01%	1150
2023 Q3	$2.86M	Buy	55,000 +40,000	+267%	+$2.33M	0.04%	487
2023 Q2	$950K	Sell	15,000 -15,000	-50%	-$935K	0.02%	673
2023 Q1	$1.62M	Buy	+30,000	New	+$1.45M	0.03%	505
2022 Q3	–	Sell	-60,000	Closed	-$3.42M	–	1912
2022 Q2	$3.42M	Buy	+60,000	New	+$3.4M	0.05%	489
2022 Q1	–	Sell	-207,000	Closed	-$10.8M	–	2047
2021 Q4	$10.8M	Buy	207,000 +78,200	+61%	+$3.28M	0.12%	212
2021 Q3	$4.8M	Buy	128,800 +8,500	+7%	+$295K	0.05%	476
2021 Q2	$4.91M	Buy	120,300 +51,800	+76%	+$1.91M	0.06%	369
2021 Q1	$2.32M	Buy	68,500 +38,500	+128%	+$1.34M	0.05%	474
2020 Q4	$954K	Buy	+30,000	New	+$788K	0.02%	620
2020 Q3	–	Sell	-723,600	Closed	-$18.6M	–	1314
2020 Q2	$18.6M	Buy	723,600 +577,500	+395%	+$11.7M	0.62%	16
2020 Q1	$2.25M	Sell	146,100 -658,200	-82%	-$14.3M	0.13%	223
2019 Q4	$27.6M	Buy	804,300 +1,200	+0.1%	+$14.4K	0.93%	14
2019 Q3	$6M	Buy	803,100 +481,400	+150%	+$4.62M	0.31%	89
2019 Q2	$4.17M	Buy	321,700 +120,200	+60%	+$1.54M	0.21%	148
2019 Q1	$2.45M	Buy	+201,500	New	+$2.57M	0.14%	204

Other funds holding ITCI